SVP-ML: SVP Detection Using Machine Learning

Sponsor
King's College London (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05731765
Collaborator
(none)
210
8

Study Details

Study Description

Brief Summary

This diagnostic study will use 410 retrospectively captured fundal videos to develop ML systems that detect SVPs and quantify ICP. The ground truth will be generated from the annotations of two independent, masked clinicians, with arbitration by an ophthalmology consultant in cases of disagreement.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Machine Learning Model

Study Design

Study Type:
Observational
Anticipated Enrollment :
210 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Automated Detection of Spontaneous Venous Pulsations Within Fundal Videos Using Machine Learning
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients aged ≥18 years with presumed normal intracranial pressure

Diagnostic Test: Machine Learning Model
Automated machine learning system for the detection of spontaneous venous pulsations and quantification of intracranial pressure

Patients aged ≥18 years with suspected raised intracranial pressure

Diagnostic Test: Machine Learning Model
Automated machine learning system for the detection of spontaneous venous pulsations and quantification of intracranial pressure

Outcome Measures

Primary Outcome Measures

  1. Area-under-the receiver operating characteristic (AUROC) for spontaneous venous pulsations detection [1 year]

    Binary classification performance of the machine learning model

Secondary Outcome Measures

  1. Localisation of spontaneous venous pulsations [1 year]

    Bounding box overlap for the machine learning model

  2. Quantification of intracranial pressure [1 year]

    Mean absolute error for the prediction of the intracranial pressure

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients aged ≥18 years with presumed normal ICP undergoing routine dilated OCT scans.

  • Patients undergoing a LP or continuous ICP monitoring with implanted transcranial pressure transducer devices at in- or out-patient neurology, neurosurgery or neuro-ophthalmology services.

Exclusion Criteria:
  • Glaucoma diagnosis or glaucoma suspects in either eye.

  • Bilateral restricted fundal view, e.g. advanced bilateral cataracts.

  • Bilateral retinal vein or artery occlusion.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • King's College London

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
King's College London
ClinicalTrials.gov Identifier:
NCT05731765
Other Study ID Numbers:
  • 1.0
First Posted:
Feb 16, 2023
Last Update Posted:
Feb 16, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 16, 2023